This application requests renewal of a grant to provide state-of-the art post-doctoral training in molecular imaging. Despite a clear and growing need of the field, few opportunities now exist for providing broad, in depth, and interdisciplinary training for individuals to develop and validate novel methods for non-invasively sensing molecular and cellular processes in vivo and ultimately in patients. The program is based at the Center for Molecular Imaging Research (CMIR) at Massachusetts General Hospital and includes members of three other Harvard Hospitals as well as basic science faculty of Harvard Medical School. Former trainees are now independent investigators in academia, are associated with large pharmaceutical divisions involved inoncology drug development or are in advanced medical training. This training grant now includes 28 research faculty who were selected on the basis of proven scientific achievement, focus on basic cancer processes, mentoring skills, research program participation and the feedback and experience of postdoctoral fellows. The selected faculty is highly accomplished and includes 16 Full Professors, 7 Associate Professors,4 Assistant Professors and 1 Instructor. The faculty has over 100 extramural research grants that directly address issues of cancer diagnosis and therapy. The faculty has successfully supervised over 300 pre and postdoctoral fellows in various aspects of basic and clinical research. We have also developed successful programs in minority recruitment, scientific integrity and cancer related training and research. We feel strongly that, with our current faculty, enhanced facilities, scope of supported research, and past accomplishments, we can continue to provide an outstanding research environment for the next generation of clinicians and scientists trained in molecular imaging.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Program Officer
Damico, Mark W
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Massachusetts General Hospital
United States
Zip Code
Cuccarese, Michael F; Dubach, J Matthew; Pfirschke, Christina et al. (2017) Heterogeneity of macrophage infiltration and therapeutic response in lung carcinoma revealed by 3D organ imaging. Nat Commun 8:14293
Park, Yong Il; Kim, Eunha; Huang, Chen-Han et al. (2017) Facile Coating Strategy to Functionalize Inorganic Nanoparticles for Biosensing. Bioconjug Chem 28:33-37
Dubach, J Matthew; Kim, Eunha; Yang, Katherine et al. (2017) Quantitating drug-target engagement in single cells in vitro and in vivo. Nat Chem Biol 13:168-173
Arlauckas, Sean P; Garris, Christopher S; Kohler, Rainer H et al. (2017) In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy. Sci Transl Med 9:
Miller, Miles A; Weissleder, Ralph (2017) Imaging of anticancer drug action in single cells. Nat Rev Cancer 17:399-414
Miller, Miles A; Weissleder, Ralph (2017) Imaging the pharmacology of nanomaterials by intravital microscopy: Toward understanding their biological behavior. Adv Drug Deliv Rev 113:61-86
Im, Hyungsoon; Park, Yong Il; Pathania, Divya et al. (2016) Digital diffraction detection of protein markers for avian influenza. Lab Chip 16:1340-5
Giedt, Randy J; Fumene Feruglio, Paolo; Pathania, Divya et al. (2016) Computational imaging reveals mitochondrial morphology as a biomarker of cancer phenotype and drug response. Sci Rep 6:32985
Pucci, Ferdinando; Garris, Christopher; Lai, Charles P et al. (2016) SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactions. Science 352:242-6
Pathania, Divya; Im, Hyungsoon; Kilcoyne, Aoife et al. (2016) Holographic Assessment of Lymphoma Tissue (HALT) for Global Oncology Field Applications. Theranostics 6:1603-10

Showing the most recent 10 out of 115 publications